Last Updated: May 10, 2026

Suppliers and packagers for generic pharmaceutical drug: bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate


✉ Email this page to a colleague

« Back to Dashboard


bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bausch And Lomb NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 064068 ANDA Bausch & Lomb Incorporated 24208-785-55 1 TUBE in 1 CARTON (24208-785-55) / 3.5 g in 1 TUBE 1995-10-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Supplier Map for Bacitracin Zinc + Hydrocortisone + Neomycin Sulfate + Polymyxin B Sulfate (APIs)

Last updated: April 25, 2026

What suppliers provide BACITRACIN ZINC (API)?

Bacitracin Zinc is commonly supplied in pharma grade as an active ingredient for topical antibiotic products. The market spans global specialty API manufacturers and bulk-chemical distributors.

Supplier categories to target (typical source lists used in regulatory filings and commercial procurement):

  • API manufacturers (direct): European and North American producers of bacitracin derivatives and/or bacitracin zinc bulk
  • China-based API manufacturers (direct or via agents): producers of bacitracin zinc under pharma-grade specifications
  • Authorized distributors (GMP-to-commercial channels): firms sourcing from approved API plants and providing CoA, SDS, and traceability

Target supplier profile for qualification:

  • Regulatory documentation: DMF/CEP availability where applicable; batch CoA alignment to USP/EP where used
  • Quality system: cGMP manufacturing controls for peptide antibiotic ingredients
  • Supply continuity: multi-source ability because bacitracin production is capacity constrained seasonally

What suppliers provide HYDROCORTISONE (API)?

Hydrocortisone is a standard corticosteroid API with broad supply coverage.

Supplier categories to target:

  • Large, diversified steroid API producers (direct)
  • Specialty anti-inflammatory API manufacturers (direct)
  • Global API distributors with confirmed GMP sourcing (authorized distribution)

Target supplier profile for qualification:

  • CoA release parameters: identity, assay, impurities, residual solvents, microbiological spec if required
  • Crystallinity/form control: consistent polymorph or grade tied to the dosage form
  • Regulatory support: DMF or equivalent submission-ready documentation

What suppliers provide NEOMYCIN SULFATE (API)?

Neomycin sulfate is usually supplied as bulk antibiotic API for topical and ophthalmic uses.

Supplier categories to target:

  • Antibiotic fermentation API manufacturers (direct)
  • Specialty antibiotic API producers (direct)
  • Authorized distributors (for customers needing quick supply with full documentation)

Target supplier profile for qualification:

  • Potency/assay consistency: neomycin content ranges must match the formulation need
  • Salt form control: sulfate composition and spec adherence
  • Allergen-risk handling: supplier documented containment and handling procedures

What suppliers provide POLYMYXIN B SULFATE (API)?

Polymyxin B sulfate is an antibiotic API with more limited qualified supply compared with hydrocortisone.

Supplier categories to target:

  • Specialty antibiotic API producers (direct)
  • Firms with fermentation-derived antibiotic capability (direct)
  • Authorized distributors with confirmed GMP sourcing and stable allocations

Target supplier profile for qualification:

  • Potency and impurity control: batch-to-batch potency and impurity profile consistency
  • Supply reliability: polymyxin B supply can tighten quickly due to production cycles

How should procurement teams structure supplier sourcing for this 4-API combination?

For combination topical products containing:

  • Bacitracin zinc
  • Hydrocortisone
  • Neomycin sulfate
  • Polymyxin B sulfate

the practical sourcing strategy is to treat each API as a separate risk line item while enforcing a unified qualification package.

Qualification pack to demand uniformly across suppliers

  • GMP status and manufacturing site qualification
  • CoA for at least 3 non-consecutive batches
  • Analytical method summary (at least identity tests plus assay and impurities)
  • Impurity profile aligned to your internal specification or pharmacopeia
  • Regulatory documents (DMF/CEP where applicable)

Commercial risk control

  • At least 2 suppliers per API where market structure allows
  • Single-plant dependence avoidance for bacitracin and polymyxin B due to capacity variability
  • Distribution channel restrictions: prioritize direct API supply or authorized distributors with traceable batch lineage

Key Takeaways

  • The supply base for hydrocortisone is broad; bacitracin zinc and polymyxin B sulfate require tighter supplier screening for continuity.
  • Build procurement around API-by-API qualification with a standardized documentation pack: CoA, GMP evidence, analytical method alignment, and batch impurity controls.
  • Use multi-source sourcing for antibiotics and enforce traceable batch lineage to reduce regulatory and supply shocks.

FAQs

  1. Can one supplier provide all four APIs (bacitracin zinc, hydrocortisone, neomycin sulfate, polymyxin B sulfate)?
    It is possible, but not typically efficient; procurement usually sources each API from specialized manufacturers or authorized distributors.

  2. Which API typically has the tightest supply constraints?
    Polymyxin B sulfate and bacitracin zinc often show more constrained capacity and tighter allocations than hydrocortisone.

  3. What documents matter most for API qualification?
    Batch CoA (multiple lots), GMP evidence, method/assay support, and regulatory dossier materials such as DMF/CEP where applicable.

  4. Are distributors acceptable for these APIs?
    Yes if they are authorized and provide full traceability, CoA, and GMP-compliant batch sourcing.

  5. What quality attributes drive formulation risk for antibiotics?
    Potency/assay and impurity profile consistency across multiple lots, plus salt/form control for neomycin sulfate and polymyxin B sulfate.


References

[1] U.S. FDA. “Drug Master Files (DMF).” FDA. https://www.fda.gov/drugs/development-approval-process-drugs/drug-master-files-dmf
[2] European Medicines Agency. “CEP: Certificates of Suitability to the Monographs of the European Pharmacopoeia.” EMA. https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/certificates-suitability-monographs-european-pharmacopoeia
[3] U.S. Pharmacopeia. “USP Monographs (Bacitracin Zinc, Hydrocortisone, Neomycin Sulfate, Polymyxin B Sulfate).” USP. https://www.uspnf.com/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing